OLENOX INDUSTRIES INC. (OLOX): Nasdaq/NYSE listing notice — Safe & Green Holdings receives Nasdaq bid price deficiency notice

OLENOX INDUSTRIES INC.

Received Nasdaq notice on Dec 12, 2024 for failing $1.00 minimum bid for 30 consecutive business days.
Has until June 10, 2025 to regain compliance by closing at $1.00+ for 10 consecutive days.
If not compliant by June 10, 2025, may qualify for additional 180-day cure period.
Company considering reverse stock split but no assurance of regaining compliance.
Stock continues trading on Nasdaq Capital Market under SGBX; no immediate delisting.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

OLENOX INDUSTRIES INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

December 12, 2024, Safe & Green Holdings Corp. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the preceding 30 consecutive business days (October 30, 2024 through December 11, 2024), the Company’s common stock did not maintain a minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”) as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade on

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

OLENOX INDUSTRIES INC. filing history →

Source: SEC EDGAR

accession 0001213900-24-109286

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.